The estimated glomerular filtration rate (eGFR) is the most comprehensive indicator for assessing and staging the status of a patient's baseline renal function. While creatinine is used in the calculation, eGFR provides a more accurate picture of kidney function by adjusting for age, sex, and race. Clinical practice guidelines use eGFR levels to classify chronic kidney disease (CKD) into stages (1 through 5), which directly supports a query for a more specific diagnosis reflecting the patient's functional status.

A. Creatinine is a component of the eGFR calculation but is less informative on its own, as normal ranges can vary significantly between individuals.

B. BUN is a less specific marker of renal function and can be influenced by non-renal factors like diet, hydration, and liver disease.

D. ACR is primarily used to detect albuminuria, an indicator of kidney damage (especially early damage), rather than to quantify the overall level of kidney function (filtration rate).

1. National Kidney Foundation. (2022). KDOQI Clinical Practice Guideline for Diabetes and CKD: 2022 Update. Chapter 2: "CKD Screening and Diagnosis," Recommendation 2.1.1 states that CKD should be diagnosed based on low eGFR and/or markers of kidney damage.

2. Levey, A. S., & Coresh, J. (2012). Chronic kidney disease. The Lancet, 379(9811), 165-180. https://doi.org/10.1016/S0140-6736(11)60178-5. (Discusses the central role of GFR in the definition and classification of CKD).

3. Stanford University School of Medicine. (n.d.). Chronic Kidney Disease (CKD). Courseware, Nephrology curriculum. Describes staging of CKD based on eGFR levels.